Highline Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPL Financial
LPLA
|
+$44.3M |
| 2 |
Boston Scientific
BSX
|
+$43.2M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$34.7M |
| 4 |
Humana
HUM
|
+$22.8M |
| 5 |
Palo Alto Networks
PANW
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$37.5M |
| 2 |
Alibaba
BABA
|
+$29.3M |
| 3 |
MTOR
MERITOR, Inc.
MTOR
|
+$27.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$25.6M |
| 5 |
Caesars Entertainment
CZR
|
+$24.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.35% |
| 2 | Consumer Discretionary | 19.93% |
| 3 | Technology | 18.05% |
| 4 | Consumer Staples | 13.06% |
| 5 | Financials | 7.53% |
Similar funds
Highline Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Highline Capital Management held 31 positions worth $631M, down 7.9% from $685M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Highline Capital Management withdrew a net $152M in Q4 2019, closing 9 positions and reducing 16 holdings. Its most notable exit was Progressive, an estimated $37.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Highline Capital Management opened a new position in LPL Financial worth $47.6M.
- Highline Capital Management's largest Q4 2019 buy was LPL Financial: 515,604 shares worth $47.6M.
- Highline Capital Management's biggest Q4 2019 reduction was Alibaba, cutting an estimated $29.3M.
- Highline Capital Management fully exited Progressive in Q4 2019, selling an estimated $37.5M.
- Highline Capital Management's ten largest holdings make up 67% of its $631M portfolio in Q4 2019.
- Highline Capital Management opened 6 new positions and closed 9 in Q4 2019.
- Highline Capital Management's portfolio value fell 7.9% quarter-over-quarter to $631M.
Based on Highline Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.